Lynx1 Capital Management LP Reports 10.7% Stake in Korro Bio, Inc. (KRRO)

2026-04-02SEC Filing SCHEDULE 13G/A (0000902664-26-001846)

On April 2, 2026, Lynx1 Capital Management LP filed a Schedule 13G/A with the SEC, reporting a significant stake in Korro Bio, Inc. (KRRO). The filing indicates that the investment manager, along with Mr. Weston Nichols, beneficially owns 1,538,296 shares of Common Stock, representing a 10.7% ownership stake in the company. This position is held directly by the Lynx1 Master Fund LP. The filing is an amendment to a previous statement, marking a substantial increase from a reported 0% in prior snapshots to the current 10.7% threshold. The reporting persons have shared voting and dispositive power over the reported shares. The calculation of the ownership percentage is based on 14,422,571 shares of Common Stock outstanding as of March 11, 2026. The filing includes a certification that the shares were not acquired for the purpose of changing or influencing the control of the issuer, maintaining a passive investment intent.